Varicella (Chickenpox): Clinical Trials

5 trials for Varicella (Chickenpox), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 not yet recruiting. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Recruiting 3, Not yet recruiting 2

Follow Varicella (Chickenpox): new trials by email Literature Review of Varicella (Chickenpox) trials Research Report on Varicella (Chickenpox)

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age
MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps
Phase 3Not yet recruitingGlaxoSmithKline18602026-08-112026-08-03
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
NBP608 (Mid Potency), NBP608 (Low Potency), Varivax® - Varicella (Chickenpox)
Phase 3RecruitingSK Bioscience Co., Ltd.7802026-07-042026-09-15
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children
Varicella Vaccine - Varicella (Chickenpox), Varicella Immunisation
Phase 3Not yet recruitingSinovac (Dalian) Vaccine Technology Co., Ltd.3002026-06-152026-06-12
A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years
MG1111 (Barycela inj.), VARIVAX™ - Varicella (Chickenpox), Chickenpox Vaccine
Phase 3RecruitingGC Biopharma Corp4742026-03-172026-04-17
Second Dose of Varicella Vaccine in Healthy Children
PROVARIX - Varicella (Chickenpox), Varicella Immunisation
Phase 3RecruitingSinovac (Dalian) Vaccine Technology Co., Ltd.3002026-01-282026-03-16

Narrower conditions

Chickenpox (5)  ·  Measles (1)  ·  Mumps (1)  ·  Rubella (1)

Broader conditions

DNA Virus Infections (5)  ·  Herpesviridae Infections (5)  ·  Infections (5)  ·  Varicella Zoster Virus Infection (5)  ·  Virus Diseases (5)  ·  Mononegavirales Infections (1)  ·  Morbillivirus Infections (1)  ·  Mouth Diseases (1)  ·  Paramyxoviridae Infections (1)  ·  Parotid Diseases (1)  ·  Parotitis (1)  ·  RNA Virus Infections (1)  ·  Rubivirus Infections (1)  ·  Rubulavirus Infections (1)  ·  Salivary Gland Diseases (1)

Interventions

Chickenpox Vaccine (3)  ·  DTPP vaccine (1)  ·  Saline Solution (1)  ·  measles, mumps, rubella, varicella vaccine (1)

Sponsors

Sinovac (Dalian) Vaccine Technology Co., Ltd. (2)  ·  GC Biopharma Corp (1)  ·  GlaxoSmithKline (1)  ·  SK Bioscience Co., Ltd. (1)

Countries

Thailand (2)  ·  Argentina (1)  ·  Finland (1)  ·  Honduras (1)  ·  Italy (1)  ·  Philippines (1)  ·  Puerto Rico (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)  ·  Vietnam (1)

NIH funding

2025 (1)